| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Revenue | ||||
| Cost of revenue | ||||
| Operating income | ||||
| Operating margin | ||||
| Net income | ||||
| Net profit margin | ||||
| Cash on hand | ||||
| Change in cash | ||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm | 9.56 mm |
| Cash burn (monthly) | 726.33 k | (no burn) | 942.67 k | 842.92 k | 731.33 k | 729.00 k |
| Cash used (since last report) | 3.69 mm | n/a | 4.79 mm | 4.29 mm | 3.72 mm | 3.71 mm |
| Cash remaining | 5.87 mm | n/a | 4.77 mm | 5.28 mm | 5.84 mm | 5.86 mm |
| Runway (months of cash) | 8.1 | n/a | 5.1 | 6.3 | 8.0 | 8.0 |
| 13F holders | Current |
|---|---|
| Total holders | 12 |
| Opened positions | 8 |
| Closed positions | 2 |
| Increased positions | 1 |
| Reduced positions | 0 |
| 13F shares | Current |
|---|---|
| Total value | 1.92 bn |
| Total shares | 3.08 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| BMO Bank of Montreal | 975.00 k | $1.03 bn |
| Kamran Najmabadi | 731.25 k | $3.54 mm |
| BSX Boston Scientific | 543.97 k | $2.63 mm |
| ADAR1 Capital Management | 315.19 k | $334.10 mm |
| Geode Capital Management | 232.94 k | $246.93 mm |
| Nixon Peabody Trust | 97.17 k | $103.00 mm |
| Vanguard | 56.74 k | $60.14 mm |
| Charles Schwab Investment Management | 49.23 k | $52.19 mm |
| Kestra Advisory Services | 35.52 k | $37.65 mm |
| STT State Street | 26.15 k | $27.72 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 Oct 24 | Kirsten Angela Macfarlane | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
| 1 Oct 24 | Una S Ryan | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
| 1 Oct 24 | Laurence Marton | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
| 1 Oct 24 | Spiegel Robert J. | Stock Options Common Stock | Grant | Acquire A | No | No | 1.02 | 25,099 | 25.60 k | 25,099 |
| 6 Mar 24 | Leesa Gentry | Options Common Stock | Grant | Acquire A | No | No | 1.69 | 190,000 | 321.10 k | 190,000 |
